Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
01/2002
01/17/2002WO2002004501A1 A novel polypeptide - human beta-glucuronidase 11.88 and a polynucleotide encoding the same
01/17/2002WO2002004498A1 A NOVEL POLYPEPTIDE - THE HUMAN ALPHA-2,3 SIALYLTRANSFERASE(ST3 Gal VI) 9.57 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
01/17/2002WO2002004491A2 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
01/17/2002WO2002004490A2 Lipid metabolism molecules
01/17/2002WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/17/2002WO2002004425A2 Viral polymerase inhibitors
01/17/2002WO2002004423A1 Thrombin inhibitors comprising an aminoisoquinoline group
01/17/2002WO2002004022A1 High fidelity polymerases and uses thereof
01/17/2002WO2002004011A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme
01/17/2002WO2002004008A2 Methods of therapy with thrombin derived peptides
01/17/2002WO2002003981A1 Method of making teprenone
01/17/2002WO2002003805A1 Method of preparing a dough or a baked product made from a dough, with addition of lipolytic enzymes
01/17/2002WO2002003791A2 Transgenic mice containing targeted gene disruptions
01/17/2002WO2002003790A2 Transgenic mice containing targeted kinase gene disruptions
01/17/2002WO2002003788A2 Transgenic mice containing targeted phosphatase gene disruptions
01/17/2002WO2002003787A2 Transgenic mice containing targeted gene disruptions
01/17/2002WO2001060985A3 Compositions, methods and kits relating to uridine phosphorylase gene mutations
01/17/2002WO2001049837A3 Process for the synthesis of vertebrate telomeric dna
01/17/2002WO2001044448A3 Human oxidoreductase proteins
01/17/2002WO2001034817A3 Genes encoding enzymes for lignin biosynthesis and uses thereof
01/17/2002WO2001034091A3 Modification of polysaccharide containing materials
01/17/2002WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
01/17/2002WO2001031344A3 Glycerol as a predictor of glucose tolerance
01/17/2002WO2001031051A3 Antisense modulation of protein kinase c-theta expression
01/17/2002WO2001029230A3 Engineering disease resistance with pectate lyase-like genes
01/17/2002WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same
01/17/2002WO2001023589A3 23431, a novel human ubiquitin protease
01/17/2002WO2001023541A3 Compositions and methods for altering gene expression
01/17/2002WO2001020019A3 Implantable glucose sensor
01/17/2002WO2001016366A3 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks
01/17/2002WO2001016308A3 Plant sterol acyltransferases
01/17/2002WO2001016293A3 Dna encoding the human serine protease t
01/17/2002WO2001007613A3 Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
01/17/2002WO2000063391A3 Nucleic acid sequences to proteins involved in tocopherol synthesis
01/17/2002US20020007499 DNA sequence; transgenic plants; enzyme preferentially produces erucic acid triglycerides such as trierucin; vegetable oil
01/17/2002US20020007053 Genetic engineering; herbicide tolerant transgenic plants; efficiency
01/17/2002US20020007052 Point mutations; genetic engineering; hybridization
01/17/2002US20020007051 Producing population of hybrid nucleic acid molecules via mixing populations of nucleic acid molecules containing multiple recombination sites; genetic engineering; gene expression
01/17/2002US20020007046 Polypeptides for use in the diagnosis, prevention and treatment of cancer and immunological defects
01/17/2002US20020006655 Enzymatic polypeptide for use in infant food processing
01/17/2002US20020006654 Isolated cathepsin L type cysteine proteases and reducing intercorneocyte cohesion/promoting desquamation therewith
01/17/2002US20020006653 Nucleotide sequences coding enzymatic polypeptide; for use in the treatment of cancers, nervous system, cardiovascular, brain, prostatic and muscle disorder
01/17/2002US20020006652 Nucleic acids encoding polypeptides having haloperoxidase activity
01/17/2002US20020006651 To convert ethyl 4-chloroacetoacetate using NADPH as a coenzyme to produce ethyl (S)-4-chloro-3-hydroxybutyrate; substrate specificity, no activity to ethyl acetoacetate, specified optimal pH and temperature; enzyme from candida
01/17/2002US20020006649 Matrix; for use in wound healing
01/17/2002US20020006647 Fermentation with a phytase
01/17/2002US20020006646 Enzyme reaction method and a method for enzymatically producing an optically active cyanohydrin
01/17/2002US20020006645 Producing (S)-4-hydroxy-2-ketoglutaric acid and compounds which are formed by biosynthesis from this precursor using recombinant microorganism carrying a recombinant DNA harboring this acid aldolase gene, sugar and glyoxylic acid
01/17/2002US20020006637 Particle-mediated transformation of animal tissue cells
01/17/2002US20020006636 Chaperonin and osmolyte protein folding and related screening methods
01/17/2002US20020006618 Detecting modulators of enzyme activities; mix nuxleotide sequences and modulator, detect complex between modulator and enzymatic polypeptides,
01/17/2002US20020006397 Delivering a cytotoxic agent which is one or more of herpes simplex virus thymidine kinase (HSV-tk), gancicolvir, or a rejection antigen, into a antigenic biniding protein APBP molecule to induce lysis of target cell
01/17/2002DE10032173A1 Neue für das plsC-Gen kodierende Nukleotidsequenzen New coding for the plsC gene nucleotide sequences
01/17/2002CA2415967A1 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
01/17/2002CA2415897A1 Real-time sequence determination
01/17/2002CA2415790A1 Sinapolyglucose : malate sinapolyltransferase forms malate conjugates from benozic acid glucosides
01/17/2002CA2415778A1 Methods of therapy with thrombin derived peptides
01/17/2002CA2415767A1 High fidelity polymerases and uses thereof
01/17/2002CA2415464A1 Method for the production of hydroxylated collagen-like compounds
01/17/2002CA2415382A1 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
01/17/2002CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
01/17/2002CA2415083A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme
01/17/2002CA2414495A1 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/17/2002CA2414408A1 Methods for regulating beta-oxidation in plants
01/17/2002CA2414387A1 Drug metabolizing enzymes
01/17/2002CA2414219A1 Lipid metabolism molecules
01/17/2002CA2413810A1 Aminoacyl trna synthetases
01/17/2002CA2413035A1 Thrombin inhibitors comprising an aminoisoquinoline group
01/17/2002CA2351110A1 Helicobacter felis vaccine
01/16/2002EP1172442A1 Vitamin d derivatives and process for producing the same
01/16/2002EP1172440A1 Novel mannose isomerase and dna encoding the enzyme
01/16/2002EP1172439A1 Thermostable enzyme having aminotransferase activity and gene encoding the same
01/16/2002EP1172438A1 Polyhyroxyalkanoate synthase and gene encoding the same enzyme
01/16/2002EP1172437A1 Novel desensitized aspartokinase
01/16/2002EP1172436A1 Ceramidase gene
01/16/2002EP1171628A2 Compound screening methods
01/16/2002EP1171615A2 Cell culture process for glycoproteins
01/16/2002EP1171614A1 Dsp-4 dual-specificity map kinase phosphatase
01/16/2002EP1171613A1 Dsp-7 dual-specificity map kinase phosphatase
01/16/2002EP1171612A2 Telomerase-specific cancer vaccine
01/16/2002EP1171611A1 Splice variant of p101 protein
01/16/2002EP1171610A1 Nucleic acid sequences to proteins involved in isoprenoid synthesis
01/16/2002EP1171609A2 Lipoxygenase proteins and polynucleotides encoding the same
01/16/2002EP1171604A2 Dna sequence and recombinant production of a graminae allergen
01/16/2002EP1171602A1 Anti-angiogenic intestinal peptides, zdint5
01/16/2002EP1171601A2 Nucleic acids encoding a mutt domain-containing polypeptide
01/16/2002EP1171581A1 Lipase variant
01/16/2002EP1171580A2 Human homologues of fused gene
01/16/2002EP1171574A1 Method for obtaining aspergillus niger cultures and their uses for producing ferulic acid and vanillic acid
01/16/2002EP1171563A1 Enzyme composite particles having an acidic barrier and a physical barrier coating
01/16/2002EP1171157A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
01/16/2002EP1171143A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
01/16/2002EP1171142A1 Inflammatory mediation obtained from atractylodes lancea
01/16/2002EP1171078A2 Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol
01/16/2002EP1170994A1 Transgenic animals expressing salivary proteins
01/16/2002EP0840791B1 Generation of immune responses to prostate-specific antigen (psa)
01/16/2002EP0782580A4 Parallel selex
01/16/2002EP0742903B1 Piperidine analogs and conjugates of procainamide and napa
01/16/2002EP0672180B1 Oligonucleotide modulation of protein kinase c
01/16/2002CN1331751A Improved i(in vivo) prodn. of cephalosporins